epithelix产品代理
epithelix产品代理
Epithelix 是一家生物技术公司，成立于 2006 年 3 月，位于瑞士日内瓦。它的创始人是来自日内瓦大学的经验丰富的科学家，他们在人类和动物组织的体外重建方面拥有特殊的专业知识和专业知识。该公司自筹资金，证明了其经济可行性，并于 2007 年 12 月投资了独立的研究和生产设施。该公司是欧洲领先的体外重组人体呼吸组织和相关服务的领先供应商，为领先的学术研究实验室提供服务。 Epithelix 还供应和支持个人护理、医疗设备以及化学和制药。
Epithelix 开发了一种独特的技术，使重建的组织能够长时间保持稳态；换句话说，组织在形态和功能上都类似于天然组织（参见我们的产品页面）。该公司最初专注于呼吸系统并销售 MucilAir™，这是唯一一种能够保持完全分化和功能超过一年的人类呼吸上皮模型。该模型已商业化，可在美国、欧洲和亚洲使用。
虽然我们主要参与临床前研究的体外解决方案，但我们也积极参与多个与临床治疗目的相关的研究项目，用于治疗患有呼吸系统疾病（如癌症）的患者。
Epithelix 还使用自己的商业化产品，作为 CRO 在其实验室中提供创新的体外测试服务（请参阅我们的服务页面）。
Epithelix总部位于靠近瑞士日内瓦的Plan-les-Ouates，在法国设有子公司。 Epithelix 因其科学和商业成就而获得多项国家和国际奖项的认可。
Epithelix Sàrl provides alternative in vitro solutions to animal experimentation for evaluating the effects of drugs in development and assess the toxicity of chemical compounds on the human respiratory tract.
Epithelix is a biotech company founded in March 2006 and located in Geneva, Switzerland. Its founders are experienced scientists from University of Geneva with special expertise and know-how for in vitro reconstitutions of human and animal tissues. The company, being self-financed, proved its economic viability and invested in independent research and production facilities in December 2007. The company is the European leading provider of in vitro reconstituted human respiratory tissues and related services to leading academic research laboratories. Epithelix also supplies and supports Personal Care, Medical Device, as well as Chemical and Pharmaceutical.
Epithelix developed a unique technology allowing reconstituted tissues to be maintained at a homeostatic state for a long period of time; in other words, the tissues resemble the native tissue both morphologically and functionally (see our products page). The company focused initially on the respiratory system and marketed MucilAir™, the only human respiratory epithelium model able to remain fully differentiated and functional for more than one year. This
model is commercialized and available in US, Europe and Asia.
Although we are mainly involved in the in vitro solutions for preclinical researches, we are also active in several research projects related to clinical therapeutic purposes, for treating patients suffering from respiratory diseases such as cancers.
Using its own commercialized products, Epithelix also offers, as a CRO, innovative in vitro testing services in its laboratory (see our services page).
Epithelix is headquartered in Plan-les-Ouates, close to Geneva, Switzerland with a subsidiary in France. Epithelix has been recognized for its scientific and commercial achievements with a number of national and international awards.
